REGENESIS BIOMEDICAL, INC.
SCOTTSDALE, AZ

Regenesis Biomedical, Inc., founded in 1997, is a Delaware C corporation based in Scottsdale, Arizona. The company is dedicated to enhancing human welfare through the development, manufacture, and delivery of energy-based medical products that alleviate pain, restore health, and improve life quality. Regenesis holds strong values including dedication, innovation, integrity, respect, excellence, compassion, and teamwork. Their clientele includes healthcare facilities and practitioners serving patients in diverse settings like acute care hospitals, rehabilitation centers, outpatient clinics, and patient homes under physician orders. Regenesis is privately held with investment from venture capital firms, management, and private investors. The company's notable product, Provant, is a medical device that significantly reduces pain and swelling from operative procedures by inducing endogenous opioids to manage inflammation effectively. The leadership team of Regenesis features Mr. Brooks as President and CEO, who has been with the company since January 2012. Prior to his role at Regenesis, he held senior executive positions across major healthcare organizations like BSN Medical and Kinetic Concepts Inc., contributing significantly to sales expansion and management development. Mr. Genge, CFO and Treasurer, began with the firm in early 2007, bringing over 35 years of financial expertise from managing rapid growth in medical device companies through IPOs, compliance programs, and strategic alliances. His career spans roles at Novavax Inc., Pyxis Corporation, Ligand Pharmaceuticals, among others. Mr. Robey, who joined Regenesis with extensive marketing experience from Kinetic Concepts, led product management and strategy development that saw significant sales growth for the V.A.C. Therapy brand. His background in biomedical engineering enhances his proficiency at integrating technical knowledge with market needs. Regenesis' scientific prowess is bolstered by Dr. Moffett, Ph.D., whose multidisciplinary research delves into molecular biology and electromagnetic fields implications on biological systems, furthering the company’s innovative edge. Richard D. Shirk also serves on the board, offering over 30 years of expertise in healthcare insurance and investment management, adding valuable leadership insight to the firm. Regenesis Biomedical is actively incorporated under Florida law with the status 'For Profit.' The last annual report was filed on March 6, 2024. Their headquarters is located at 5301 North Pima Road, Suite 150, Scottsdale, Arizona, reachable via phones: (877) 970-4970; (866) 857-8792 or through their website.